Showing results (1601-1610 of 5,060) with videos related to
Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|November 23, 2015
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptorsMiguel Moreno-Martet, Ana Feliú, Francisco Espejo-Porras, et al.Multiple Sclerosis and Related Disorders|November 23, 2015
Novel composite MRI scale correlates highly with disability in multiple sclerosis patientsPeter Kosa, Mika Komori, Ryan Waters, et al.Multiple Sclerosis and Related Disorders|November 23, 2015
Placebo controlled trials in neuromyelitis optica are needed and ethicalBruce A C CreeMultiple Sclerosis and Related Disorders|November 23, 2015
Neuro-oncology dilemma: Tumour or tumefactive demyelinating lesionMohammad Abdoli, Mark S FreedmanMultiple Sclerosis and Related Disorders|November 23, 2015
A placebo controlled trial for an NMO relapse prevention treatment: Ethical considerationsRosamond RhodesMultiple Sclerosis and Related Disorders|November 23, 2015
Primary spinal oligoastrocytoma mimicking longitudinally extensive transverse myelitisT R Yeo, C F Wong, J J X Lee, et al.Multiple Sclerosis and Related Disorders|February 10, 2016
Identifying clues to molecular etiology of multiple sclerosis in South Indian patientsDhanya Joseph, Suresh KumarMultiple Sclerosis and Related Disorders|February 10, 2016
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosisK M Fiest, J R Walker, C N Bernstein, et al.Multiple Sclerosis and Related Disorders|February 10, 2016
Spasticity in multiple sclerosis: Associations with impairments and overall quality of lifeK Milinis, A Tennant, C A Young, et al.Multiple Sclerosis and Related Disorders|February 10, 2016
The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosisJoe Datt, Laura Baldock, Emily Pull, et al.Pageof 506